Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Regenxbio (RGNX) over the last 8 years, with Q3 2025 value amounting to $648000.0.

  • Regenxbio's Other Non-Current Liabilities fell 9815.13% to $648000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $648000.0, marking a year-over-year decrease of 9815.13%. This contributed to the annual value of $3.6 million for FY2024, which is 9164.08% down from last year.
  • Regenxbio's Other Non-Current Liabilities amounted to $648000.0 in Q3 2025, which was down 9815.13% from $664000.0 recorded in Q2 2025.
  • Regenxbio's Other Non-Current Liabilities' 5-year high stood at $171.3 million during Q4 2021, with a 5-year trough of $648000.0 in Q3 2025.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $67.4 million (2023), whereas its average is $78.1 million.
  • In the last 5 years, Regenxbio's Other Non-Current Liabilities soared by 2637981.65% in 2021 and then plummeted by 9838.36% in 2025.
  • Regenxbio's Other Non-Current Liabilities (Quarter) stood at $171.3 million in 2021, then dropped by 19.69% to $137.6 million in 2022, then tumbled by 68.4% to $43.5 million in 2023, then crashed by 91.64% to $3.6 million in 2024, then tumbled by 82.17% to $648000.0 in 2025.
  • Its Other Non-Current Liabilities was $648000.0 in Q3 2025, compared to $664000.0 in Q2 2025 and $11.1 million in Q1 2025.